Search
forResearch 10 of 1000+
- Enriching Proteolysis Targeting Chimeras with a Second Modality: When Two Are Better Than One
- Proteolysis‐Targeting Chimera (PROTAC): Current Applications and Future Directions
- Proteolysis‐targeting chimeras in cancer therapy: Targeted protein degradation for next‐generation treatment
- Evolving CRBN ligands enhance the drug-like properties of protein degraders
- Expanding the Scope of PROTACs: Opportunities and Challenges in Topical Delivery
- PROTAC Degraders of Androgen Receptor‐Integrated Dissolving Microneedles for Androgenetic Alopecia and Recrudescence Treatment via Single Topical Administration
- A Top-Down Design Approach for Generating a Peptide PROTAC Drug Targeting Androgen Receptor for Androgenetic Alopecia Therapy
- Recent Advances in Peptide Drug Discovery: Novel Strategies and Targeted Protein Degradation
- Advancing PROTAC therapeutics through chemistry-guided design of smart delivery systems
- PROTACs in 2025: from the laboratory concept to clinical breakthrough